Pharmaceutical Technology22 小时
PTS-500 by Gongwin Biopharm for Malignant Pleural Effusion: Likelihood of Approval
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Malignant Pleural Effusion.